RAD-140
Also known as: Testolone
RAD-140 (testolone) is a non-steroidal small-molecule selective androgen receptor modulator (SARM) — not a peptide — developed by Radius Health. It is NOT FDA-approved for any indication. Grey-market use for bodybuilding is associated with documented drug-induced liver injury (hepatotoxicity), testosterone suppression, and adverse cardiovascular effects. It is a WADA-prohibited substance. It is tracked in peptide-research spaces because of overlapping grey-market performance use.
Pricing for RAD-140
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No COAs on file for RAD-140
No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.
13 citations indexed for RAD-140
case-report · 2026
Spontaneous Splenic Rupture in a Patient With Recent Use of Performance-Enhancing Compounds: A Case Report and Literature Review
Atraumatic splenic rupture (ASR) is a rare but life-threatening surgical emergency that most commonly occurs in pathologically abnormal spleens. We present a unique case of ASR in a middle-aged man with recent use of performance-enhancing compounds, managed with both embolization and surgery.
case-report · 2025
Cholestatic Drug-Induced Liver Injury From Rad-140 Successfully Treated With Corticosteroids
Selective androgen receptor modulators (SARMs) are anabolic compounds that modulate androgen activity. They have been increasingly used in supplements to enhance performance and muscle growth despite not being Food and Drug Administration approved.
Study · 2025
A SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5‑Alpha Reductase Proteins
This study examines the molecular interactions of selective androgen receptor modulators (SARMs) with the androgen receptor (AR) and 5-alpha reductase II (5αRII), highlighting their potential as dual-action pharmacological candidates, using molecular modeling techniques to evaluate their primary interactions, providing…
Study · 2025
Rapid detection of illegal selective androgen receptor modulators in unregistered supplements using a combination of selected solid-state analytical methods
Background and purpose Pharmaceutical crime is becoming an increasingly serious threat. For customs officers and police officers, minimal or no sample preparation before analysis is essential when detecting prohibited compounds/counterfeit products, ideally using on-site analysis.
case-report · 2025
Silent Threats to the Liver: Acute Hepatotoxicity Attributed to Selective Androgen Receptor Modulators (SARMs)
Selective androgen receptor modulators (SARMs) have garnered significant attention in recent years due to their potential to improve muscle mass and athletic performance with reduced androgenic side effects compared to traditional anabolic steroids.
case-report · 2024
Selective Androgen Receptor Modulators Leading to Liver Injury: A Case Report
Selective androgen receptor modulators (SARMs) have gained popularity for their alleged ability to selectively target androgen receptors, potentially offering muscle-building benefits with fewer side effects than traditional steroids. However, the safety profile of SARMs, including RAD-140, is not fully understood.